Cargando…
Complement activation and effect of eculizumab in scleroderma renal crisis
BACKGROUND: Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis characterized by abrupt onset of hypertension, thrombotic microangiopathy, and kidney injury. The mechanisms of the disease remain ill-defined, but a growing body of evidence suggests that activation...
Autores principales: | Devresse, Arnaud, Aydin, Selda, Le Quintrec, Moglie, Demoulin, Nathalie, Stordeur, Patrick, Lambert, Catherine, Gastoldi, Sara, Pirson, Yves, Jadoul, Michel, Morelle, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265879/ https://www.ncbi.nlm.nih.gov/pubmed/27472742 http://dx.doi.org/10.1097/MD.0000000000004459 |
Ejemplares similares
-
Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
por: Gillion, Valentine, et al.
Publicado: (2021) -
Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016) -
Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy
por: Buysschaert, Benoit, et al.
Publicado: (2020) -
Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report
por: Freist, Marine, et al.
Publicado: (2017) -
Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)